Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-(2-(3,5-dichloro-4-oxo-1- Pyridyl)acetamido)-3-(5-methyl-1,3,4-thiadiazol- 2-ylthiomethyl)-3-cephem-4-carboxylic Acid
2. Cefazedone Sodium
3. Cefazedone, Monosodium Salt
4. Emd 30 087
5. Emd30087
6. Refosporen
7. Refosporin
1. 56187-47-4
2. Refosporen
3. Refosporene
4. Cefazedona
5. Cefazedonum
6. (6r,7r)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
7. Cefazedone (inn)
8. Emd-30087
9. 7y86x0d799
10. (6r,7r)-7-(2-(3,5-dichloro-4-oxo-1(4h)-pyridyl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-carboxylic Acid
11. Cefazedone [inn]
12. Cefazedone [inn:ban]
13. Cefazedonum [inn-latin]
14. Cefazedona [inn-spanish]
15. (6r,7r)-7-(2-(3,5-dichloro-4-oxopyridin-1(4h)-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
16. Refosporin Sodium Salt
17. Cefazedone, Sodium Salt
18. Brn 1097746
19. Cefazedon
20. Cefazedone Acid
21. Unii-7y86x0d799
22. Refosporen;cefazedonum
23. Nsc304118
24. Cefazedone [mi]
25. Cefazedone (*sodium Salt*)
26. Cefazedone [who-dd]
27. Refosporin (*sodium Salt*)
28. Schembl49523
29. Chembl2107636
30. Gtpl12203
31. Dtxsid50204733
32. Chebi:131731
33. Zinc1567521
34. S4874
35. Ccg-269995
36. Db13778
37. (6r,7r)-7-[[2-(3,5-dichloro-4-oxo-1-pyridyl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
38. (6r-trans)7-(((3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oxy-2-ene-2-carbox Ylic Acid
39. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6r-trans)-
40. As-75724
41. Hy-121144
42. Cs-0079538
43. D07237
44. D95160
45. 187c474
46. A936727
47. Q5057222
48. (6r,7r)-7-(2-(3,5-dichloro-4-oxopyridin-1(4h)-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
49. (6r,7r)-7-[2-(3,5-dichloro-4-oxopyridin-1(4h)-yl)acetamido]-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
50. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((2-(3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6r,7r)-
51. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, 7-[[(3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-, Monosodium Salt, (6r-trans)-
52. 7-{[3,5-dichloro-4-oxopyridin-1(4h)-yl]acetamido}-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic Acid
| Molecular Weight | 548.4 g/mol |
|---|---|
| Molecular Formula | C18H15Cl2N5O5S3 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 546.9612375 g/mol |
| Monoisotopic Mass | 546.9612375 g/mol |
| Topological Polar Surface Area | 212 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 984 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DB - First-generation cephalosporins
J01DB06 - Cefazedone
ABOUT THIS PAGE
A Cefazedone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefazedone, including repackagers and relabelers. The FDA regulates Cefazedone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefazedone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cefazedone supplier is an individual or a company that provides Cefazedone active pharmaceutical ingredient (API) or Cefazedone finished formulations upon request. The Cefazedone suppliers may include Cefazedone API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefazedone Drug Master File in Korea (Cefazedone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefazedone. The MFDS reviews the Cefazedone KDMF as part of the drug registration process and uses the information provided in the Cefazedone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefazedone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefazedone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefazedone suppliers with KDMF on PharmaCompass.
Cefazedone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefazedone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefazedone GMP manufacturer or Cefazedone GMP API supplier for your needs.
A Cefazedone CoA (Certificate of Analysis) is a formal document that attests to Cefazedone's compliance with Cefazedone specifications and serves as a tool for batch-level quality control.
Cefazedone CoA mostly includes findings from lab analyses of a specific batch. For each Cefazedone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefazedone may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefazedone EP), Cefazedone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefazedone USP).
LOOKING FOR A SUPPLIER?
